OFIX Stock Analysis: Buy, Sell, or Hold?
OFIX - Orthofix Medical Inc. Common Stock (DE)
$10.01
0.00 (0.00%)
▲
5d:
-3.19%
30d:
-8.67%
90d:
-3.84%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When OFIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OFIX trades at premium valuation expecting 11.8% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: OFIX trades at premium valuation expecting 11.8% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.16
Based on -2.9% avg growth
INTRINSIC VALUE TODAY
$3.82
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OFIX is currently trading at $10.01, which is considered oversold relative to its 30-day fair value range of $10.23 to $11.83. From a valuation perspective, the stock is trading at a premium (Forward PE: 27.1) compared to its historical average (19.4). At these levels, the market is pricing in 11.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OFIX is in a downtrend. The price is currently testing key support at $9.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OFIX scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.00 (+29.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OFIX is in a downtrend. The price is currently testing key support at $9.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OFIX scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.00 (+29.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.23 -
$11.83
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.9% below Wall St target ($13.00)
- NEUTRAL: Trading at premium valuation - market expects 11.8% growth which is achievable
- CAUTION: Bottoming setup, but lagging the sector by 11% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$10.23 -
$11.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.78
Resistance Level
$10.74
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.05
Wall Street Target
$13.00
(+29.9%)
Revenue Growth (YoY)
3.8%
Profit Margin
-7.4%
Valuation Premium vs History
+11.8% premium
PE vs Historical
27.1 vs 19.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.8%
(market-implied from PE analysis)
1-Year Target
$11.19
(+12%)
2-Year Target
$12.51
(+25%)
3-Year Target
$13.99
(+40%)
3-Yr Target (if PE normalizes)
(PE: 27→19)
PE COMPRESSION
$10.03
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.1, Growth: -9.8%)
$7.36
(+-27%)
Base:
(SPY PE: 20.1, Growth: -9.8%)
$5.46
(-46%)
Bear:
(PE: 17.1, Growth: -9.8%)
$4.64
(-54%)
Share & Embed Analysis
Last updated: August 24, 2026 6:57 AM ET
Data refreshes hourly during market hours. Next update: 7:57 AM
Data refreshes hourly during market hours. Next update: 7:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OFIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Jorge Andres Cedron
SELL
3743 shares
2026-04-16
Lucas Vitale
SELL
4269 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 39 SELL |
